Interventions for Weight Regain After Bariatric Surgery
NCT ID: NCT06963437
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2025-05-12
2025-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to evaluate the effects of revisional bariatric surgery (RBS), very low-calorie ketogenic diet (VLCKD), and intermittent fasting (IF) on nutritional habits and clinical outcomes (anthropometric and biochemical measurements) in patients with insufficient weight loss (IWL) or weight regain (WR) after bariatric surgery, and to compare these findings with those of a control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
One-Year Outcomes After Conversion Bariatric Surgery
NCT07345429
Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain After Bariatric Surgery
NCT06766747
Ketogenic Diet Prior to Bariatric Surgery
NCT06850493
Nutritional Status After Sleeve Gastrectomy in Morbid Obesity: 6-Month Study
NCT06368232
Low-Volume Oral Carbohydrate Feeding in Bariatric Surgery: Effects on PONV and Recovery
NCT07018440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. In patients with IWL or WR after bariatric surgery, a diet following the bariatric care guidelines (BCGs) after revisional bariatric surgery (RBS) improves nutritional habits, anthropometric, and biochemical parameters.
2. In patients with IWL or WR after bariatric surgery, VLCKD improves nutritional habits, anthropometric, and biochemical parameters.
3. In patients with IWL or WR after bariatric surgery, IF regimen improves nutritional habits, anthropometric, and biochemical parameters.
4. In patients with IWL or WR after bariatric surgery, the diet program recommended by the ASMBS as part of standard post-bariatric care improves nutritional habits, anthropometric measurements, and biochemical parameters.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
RBS Group - patients undergoing revisional bariatric surgery (RBS)
VLCKD Group - patients following a very low-calorie ketogenic diet (VLCKD)
IF Group - patients following an intermittent fasting (IF) diet
Control Group - patients receiving standard post-bariatric nutritional follow-up as recommended by the ASMBS
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Revisional bariatric surgery (RBS) group
A nutrition program in accordance with ASMBS guidelines will be implemented for patients undergoing revisional bariatric surgery.
Diet
A four-stage dietary program will be implemented in accordance with ASMBS guidelines. To the best of our knowledge, there is currently no study comparing the dietary approach following revisional bariatric surgery with ketogenic and intermittent fasting diets
Very low-calorie ketogenic diet (VLCKD) group
The daily energy intake of VLCKD will be planned as 600-800 kcal, with approximately 10% of energy from carbohydrates (\<30 g/day), 40-45% from protein, and 40-50% from fat.
Ketogenic diet
A high-protein Very Low-Calorie Ketogenic Diet (VLCKD) will be implemented as the nutritional intervention. In line with previous studies, the daily energy intake of the ketogenic diet will be planned as 600-800 kcal, with approximately 10% of energy from carbohydrates (\<30 g/day), 40-45% from protein, and 40-50% from fat. Total carbohydrate intake will be restricted to less than 30 g per day, primarily from vegetables, while fat intake will derive from natural protein sources and 10 g of olive oil per day.
Intermittent fasting (IF) group
Time-restricted intermittent fasting (16/8) will be applied. Patients in this group will follow a feeding schedule limited to an 8-hour window (16/8) for a duration of 6 weeks.
Fasting
Patients in this group will follow a time-restricted eating pattern (16/8) for a duration of 6 weeks, with food intake limited to an 8-hour window each day. Intermittent fasting will preferably be observed between 6:00 PM and 10:00 AM; however, patients may choose alternative 16-hour fasting periods such as 7:00 PM-11:00 AM or 8:00 PM-12:00 PM, depending on their individual routines. During the 8-hour feeding window, patients will adhere to the stage 4 post-bariatric dietary guidelines in accordance with ASMBS recommendations
Control group
No individualized diet will be planned; instead, patients will receive education on the stage 4 dietary guidelines recommended for lifelong adherence following bariatric surgery.
Control
No individualized diet will be planned
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet
A four-stage dietary program will be implemented in accordance with ASMBS guidelines. To the best of our knowledge, there is currently no study comparing the dietary approach following revisional bariatric surgery with ketogenic and intermittent fasting diets
Ketogenic diet
A high-protein Very Low-Calorie Ketogenic Diet (VLCKD) will be implemented as the nutritional intervention. In line with previous studies, the daily energy intake of the ketogenic diet will be planned as 600-800 kcal, with approximately 10% of energy from carbohydrates (\<30 g/day), 40-45% from protein, and 40-50% from fat. Total carbohydrate intake will be restricted to less than 30 g per day, primarily from vegetables, while fat intake will derive from natural protein sources and 10 g of olive oil per day.
Fasting
Patients in this group will follow a time-restricted eating pattern (16/8) for a duration of 6 weeks, with food intake limited to an 8-hour window each day. Intermittent fasting will preferably be observed between 6:00 PM and 10:00 AM; however, patients may choose alternative 16-hour fasting periods such as 7:00 PM-11:00 AM or 8:00 PM-12:00 PM, depending on their individual routines. During the 8-hour feeding window, patients will adhere to the stage 4 post-bariatric dietary guidelines in accordance with ASMBS recommendations
Control
No individualized diet will be planned
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiencing inadequate weight loss (IWL) within 18 months after surgery or weight regain (WR) following successful weight loss.
* Definitions used in the study:
IWL is defined as \<50% excess weight loss (EWL) 18 months postoperatively. WR is defined as \>25% regain of the lost weight (from the lowest achieved weight).
\-
Exclusion Criteria
* Patients with acute illnesses, infections, or comorbidities that may affect treatment efficacy or safety (e.g., cancer, type 1 diabetes, renal or hepatic failure, recent stroke or myocardial infarction, nephrolithiasis, substance or alcohol abuse, eating disorders, severe depression or other psychiatric disorders, inflammatory bowel disease, neoplasms, arrhythmic heart diseases, heart failure, respiratory failure).
* Patients currently receiving corticosteroid therapy.
* Professional athletes.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seher Dallı Şen
Seher Dallı Şen, PhD Candidate in Nutrition and Dietetic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Özel Nev FSM Hastanesi
Bursa, Bursa, Turkey (Türkiye)
Özel Nev FSM Hastanesi
Nilufer, Bursa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEDU-SBE-SS-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.